Holen Sie sich die Stockscreener-App
5.33
0.47%
-0.02
Schlusskurs vom Vortag:
$5.35
Offen:
$5.35
24-Stunden-Volumen:
43,091
Relative Volume:
0.01
Marktkapitalisierung:
$606.02M
Einnahmen:
$1.08M
Nettoeinkommen (Verlust:
$-106.26M
KGV:
-3.6544
EPS:
-1.4585
Netto-Cashflow:
$-106.85M
1W Leistung:
+1.04%
1M Leistung:
+9.12%
6M Leistung:
+57.54%
1J Leistung:
+113.00%
1-Tages-Spanne:
$5.32
$5.4907
1-Wochen-Bereich:
$4.77
$5.81
52-Wochen-Spanne:
$1.60
$6.16
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Compare CATX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
5.32 | 592.35M | 1.08M | -106.26M | -106.85M | -1.4585 |
|
ABT
Abbott Laboratories
|
109.98 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.32 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.70 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.33 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-11-24 | Fortgesetzt | Truist | Buy |
| 2025-10-10 | Eingeleitet | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Jobs Data: Is Perspective Therapeutics Inc stock a hidden gemGap Down & Long-Term Safe Investment Ideas - baoquankhu1.vn
Aug Sentiment: Is Perspective Therapeutics Inc part of any ETF2026 Price Targets & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Perspective Therapeutics (CATX) director awarded 50,000-share stock option grant - Stock Titan
Director at Perspective Therapeutics (CATX) awarded 50,000 stock options - Stock Titan
Director at Perspective Therapeutics (CATX) awarded 50K stock options - Stock Titan
Perspective Therapeutics (CATX) CAO receives 90,000-stock-option equity award - Stock Titan
Perspective Therapeutics (CATX) CMO receives 150,000 stock options as 2026 award - Stock Titan
CATX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CATX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CATX SEC FilingsPerspective Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Does Perspective Therapeutics Inc stock have upside surprise potential - baoquankhu1.vn
Sectors Review: Is Olin Corporation in a long term uptrend2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
Take Profit: Does Perspective Therapeutics Inc stock have upside surprise potentialShort Setup & Stock Portfolio Risk Management - baoquankhu1.vn
Perspective Therapeutics (NASDAQ:CATX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Perspective Therapeutics (CATX) and Its Rivals Head to Head Survey - Defense World
349,323 Shares in Perspective Therapeutics, Inc. $CATX Purchased by Patient Square Capital LP - MarketBeat
CATXPerspective Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Perspective Therapeutics (NASDAQ:CATX) Coverage Initiated at Piper Sandler - Defense World
Perspective Therapeutics Outperforms Rivals in Financial Review - National Today
Radioligand Therapies Market Size, Share | Growth Report 2034 - Fortune Business Insights
Perspective Therapeutics (NASDAQ:CATX) Rating Increased to Strong-Buy at Piper Sandler - MarketBeat
Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price Up 12.3%Still a Buy? - MarketBeat
Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price Up 12.3% – Still a Buy? - Defense World
Piper Sandler initiates Perspective Therapeutics stock rating at overweight By Investing.com - Investing.com Nigeria
Perspective Therapeutics (CATX) Receives a Buy from JonesTrading - The Globe and Mail
This Tempus AI Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
CATX Initiates Coverage with Overweight Rating by Piper Sandler - GuruFocus
Piper Sandler Initiates Coverage of Perspective Therapeutics (CATX) with Overweight Recommendation - Nasdaq
Piper Sandler initiates Perspective Therapeutics stock rating at overweight - Investing.com UK
Perspective Therapeutics, Inc. (CATX) Builds Momentum With Funding and Trial Progress - Insider Monkey
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else - Benzinga
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results - Bitget
Contrasting Perspective Therapeutics (CATX) and Its Peers - Defense World
Financial Review: Perspective Therapeutics (CATX) & Its Rivals - Defense World
How Perspective Therapeutics Inc. stock reacts to new regulations2025 Pullback Review & Long-Term Growth Portfolio Plans - mfd.ru
CATX Technical Analysis & Stock Price Forecast - Intellectia AI
CATX PE Ratio & Valuation, Is CATX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX) - The Globe and Mail
Can Perspective Therapeutics Inc. lead its sector in growthDividend Hike & Low Drawdown Investment Ideas - mfd.ru
Will Perspective Therapeutics Inc. benefit from rising consumer demandJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - mfd.ru
Perspective Therapeutics Outperforms Competitors in Key Metrics - National Today
Can Perspective Therapeutics Inc. expand into new marketsLayoff News & Safe Capital Investment Plans - mfd.ru
Activity Recap: Does Perspective Therapeutics Inc stock have upside surprise potentialExit Point & Technical Buy Zone Confirmations - baoquankhu1.vn
Perspective Therapeutics (CATX) Is Up 92.6% After $175M Equity Raise To Fund Targeted Alpha Therapies – Has The Bull Case Changed? - Yahoo Finance
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline - TipRanks
Perspective Therapeutics prices $175M equity offering; shares up - MSN
Perspective Therapeutics Prices Approx. $175 Mln Offering Of Shares And Pre-Funded Warrants - Nasdaq
Perspective Therapeutics (CATX) Raises $175 Million Through Stoc - GuruFocus
Perspective Therapeutics shares rise after $175 million offering By Investing.com - Investing.com South Africa
Perspective Therapeutics shares rise after $175 million offering - Investing.com
Perspective Therapeutics jumps after $175 mln equity offering - TradingView
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
Kapitalisierung:
|
Volumen (24h):